Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

NCT01654796 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01654796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01654796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Proof-of-Concept (POC) Trial of Low Field Magnetic Stimulation (LFMS) Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
September 30, 2016
Enrollment
84 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression